Title : Cell Behavior of Non-Small Cell Lung Cancer Is at EGFR and MicroRNAs Hands.

Pub. Date : 2021 Nov 19

PMID : 34830377






3 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Several EGFR-tyrosine kinase inhibitors (EGFR-TKIs), including erlotinib, gefitinib, and osimertinib, are effective therapeutic agents in EGFR-mutated NSCLC. Gefitinib epidermal growth factor receptor Rattus norvegicus
2 Several EGFR-tyrosine kinase inhibitors (EGFR-TKIs), including erlotinib, gefitinib, and osimertinib, are effective therapeutic agents in EGFR-mutated NSCLC. Gefitinib epidermal growth factor receptor Rattus norvegicus
3 Several EGFR-tyrosine kinase inhibitors (EGFR-TKIs), including erlotinib, gefitinib, and osimertinib, are effective therapeutic agents in EGFR-mutated NSCLC. Gefitinib epidermal growth factor receptor Rattus norvegicus